SALMI, Livia
 Distribuzione geografica
Continente #
EU - Europa 439
NA - Nord America 356
AS - Asia 120
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 920
Nazione #
US - Stati Uniti d'America 343
IE - Irlanda 129
IT - Italia 106
SE - Svezia 68
DE - Germania 52
HK - Hong Kong 32
IN - India 29
UA - Ucraina 27
SG - Singapore 21
FR - Francia 18
CA - Canada 13
CZ - Repubblica Ceca 13
CN - Cina 11
TR - Turchia 11
IR - Iran 8
NL - Olanda 8
GB - Regno Unito 7
VN - Vietnam 6
BE - Belgio 4
EG - Egitto 3
CH - Svizzera 2
FI - Finlandia 2
AT - Austria 1
EU - Europa 1
IL - Israele 1
LU - Lussemburgo 1
MA - Marocco 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 920
Città #
Dublin 129
Jacksonville 52
Chandler 44
Piemonte 37
Hong Kong 32
Wilmington 22
Ann Arbor 17
Grafing 15
Lawrence 15
Princeton 15
Dearborn 13
San Mateo 13
Singapore 13
Brno 10
Kocaeli 8
Bremen 7
Dong Ket 6
Beijing 5
Munich 5
Ashburn 4
Brussels 4
Cagliari 4
Castellamonte 4
Dronten 4
Novara 4
Philadelphia 4
Turin 4
Amsterdam 3
Borgo Vercelli 3
Los Angeles 3
Milan 3
Stankov 3
Strasbourg 3
Zanjan 3
Andover 2
Ardabil 2
Augusta 2
Cambridge 2
Canelli 2
Casaleggio Novara 2
Fairfield 2
Grosseto 2
Helsinki 2
Houston 2
London 2
Menlo Park 2
Monmouth Junction 2
Noicattaro 2
Norwalk 2
San Francisco 2
Santa Clara 2
Seattle 2
Woodbridge 2
Zhengzhou 2
Asti 1
Baho 1
Bangalore 1
Berlin 1
Boardman 1
Borgomanero 1
Cassano Magnago 1
Castelnuovo Scrivia 1
City of Westminster 1
Des Moines 1
Florence 1
Fuzhou 1
Guangzhou 1
Kaohsiung City 1
Leinì 1
Lugano 1
Luxembourg 1
Mumbai 1
Ottawa 1
Padova 1
Pozzallo 1
Rabat 1
Rome 1
San Diego 1
Shenyang 1
Torino 1
Toronto 1
Vercelli 1
Zurich 1
Totale 580
Nome #
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 95
Osteopontin at the Crossroads of Inflammation and Tumor Progression. 95
The Role of Osteopontin as a Diagnostic and Prognostic Biomarker in Sepsis and Septic Shock 84
Growth arrest specific 6 - Feasible marker for septic patients and potential architect in the improvement of sepsis-induced organ damage in mice 79
Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis 66
Severity of nonalcoholic fatty liver disease in type 2 diabetes mellitus: Relationship between nongenetic factors and PNPLA3/HSD17B13 polymorphisms 64
Plasma microvesicles in patients admitted to the emergency department for mild traumatic brain injury: First clues to understand their role 60
The increase in copeptin levels in mild head trauma does not predict the severity and the outcome of brain damage 57
Are Baseline Levels of Gas6 and Soluble Mer Predictors of Mortality and Organ Damage in Patients with Sepsis? The Need-Speed Trial Database 53
Hypernatremia and moderate-to-severe hyponatremia are independent predictors of mortality in septic patients at emergency department presentation: A sub-group analysis of the need-speed trial 52
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 52
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 50
Growth Arrest-Specific Gene 6 Administration Ameliorates Sepsis-Induced Organ Damage in Mice and Reduces ROS Formation In Vitro 43
ADAM17 inhibition effects on Mer shedding 35
Interferon signature in immunosuppressed patients with lower respiratory tract infections: dosage on bronchoalveolar lavage 33
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment 30
Gas6/TAM Axis in Sepsis: Time to Consider Its Potential Role as a Therapeutic Target 6
Totale 954
Categoria #
all - tutte 5.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.501


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202082 0 0 0 0 0 7 15 4 7 32 13 4
2020/2021133 9 1 13 4 28 13 12 2 12 18 15 6
2021/2022164 8 6 18 15 17 4 16 7 10 22 15 26
2022/2023320 24 17 22 3 22 26 14 14 136 3 23 16
2023/2024136 18 10 8 5 12 0 33 9 4 4 10 23
2024/202536 6 2 10 4 6 8 0 0 0 0 0 0
Totale 954